Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5)
作者:Sheo B. Singh、David E. Kaelin、Peter T. Meinke、Jin Wu、Lynn Miesel、Christopher M. Tan、David B. Olsen、Armando Lagrutta、Hideyuki Fukuda、Ryuta Kishii、Masaya Takei、Tomoko Takeuchi、Hisashi Takano、Kohei Ohata、Haruaki Kurasaki、Akinori Nishimura、Takeshi Shibata、Yasumichi Fukuda
DOI:10.1016/j.bmcl.2015.06.061
日期:2015.9
Oxabicyclooctane linked novel bacterial topoisomerase inhibitors (NBTIs) are new class of recently reported broad-spectrum antibacterial agents. They target bacterial DNA gyrase and topoisomerase IV and bind to a site different than quinolones. They show no cross-resistance to known antibiotics and provide opportunity to combat drug-resistant bacteria. A structure activity relationship of the C-2 substituted
氧杂双环辛烷连接的新型细菌拓扑异构酶抑制剂(NBTI)是最近报道的一类新型广谱抗菌剂。它们靶向细菌DNA促旋酶和拓扑异构酶IV,并结合到不同于喹诺酮的位点。它们对已知的抗生素没有交叉耐药性,并提供了对抗耐药菌的机会。描述了与1,5-萘啶氧杂双环辛烷连接的NBTI的C-2取代的醚类似物的结构活性关系。已经总结出总共63种类似物的合成和抗菌活性,它们代表烷基,环烷基,氟代烷基,羟烷基,氨基烷基和羧基烷基醚。所有化合物均针对三种革兰氏阳性菌和革兰氏阴性菌以及hERG结合活性进行了测试。还测试了许多关键化合物的功能性hERG活性。在鼠菌血症模型中评价了六种化合物的功效。金黄色葡萄球菌感染。对于金黄色葡萄球菌活性,在C-2处观察到对醚取代(包括极性基团,例如氨基和羧基)的显着耐受性,但是对于粪肠球菌和革兰氏阴性菌株而言,情况并非如此。降低的c log D通常显示出降低的hERG活性和改善的体内功